AU5861396A - Stable aqueous formulations of 1alpha,25-dihydroxycholecalci ferol for parenteral administration - Google Patents

Stable aqueous formulations of 1alpha,25-dihydroxycholecalci ferol for parenteral administration

Info

Publication number
AU5861396A
AU5861396A AU58613/96A AU5861396A AU5861396A AU 5861396 A AU5861396 A AU 5861396A AU 58613/96 A AU58613/96 A AU 58613/96A AU 5861396 A AU5861396 A AU 5861396A AU 5861396 A AU5861396 A AU 5861396A
Authority
AU
Australia
Prior art keywords
dihydroxycholecalci
ferol
1alpha
parenteral administration
stable aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58613/96A
Inventor
Luk C. Li
Jagdish Parasrampuria
Edward A. Pec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU5861396A publication Critical patent/AU5861396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU58613/96A 1995-05-19 1996-05-16 Stable aqueous formulations of 1alpha,25-dihydroxycholecalci ferol for parenteral administration Abandoned AU5861396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44498295A 1995-05-19 1995-05-19
US444982 1995-05-19
PCT/US1996/007074 WO1996036340A1 (en) 1995-05-19 1996-05-16 STABLE AQUEOUS FORMULATIONS OF 1α,25-DIHYDROXYCHOLECALCIFEROL FOR PARENTERAL ADMINISTRATION

Publications (1)

Publication Number Publication Date
AU5861396A true AU5861396A (en) 1996-11-29

Family

ID=23767175

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58613/96A Abandoned AU5861396A (en) 1995-05-19 1996-05-16 Stable aqueous formulations of 1alpha,25-dihydroxycholecalci ferol for parenteral administration

Country Status (2)

Country Link
AU (1) AU5861396A (en)
WO (1) WO1996036340A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
PT1171100E (en) * 1999-04-13 2003-11-28 Leo Pharma As PHARMACEUTICAL COMPOSITION SOLUBILIZED FOR PARENTAL ADMINISTRATION
US6051567A (en) * 1999-08-02 2000-04-18 Abbott Laboratories Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
US6211169B1 (en) * 1999-09-29 2001-04-03 Aesgen, Inc. Stable calcitriol solution for packaging into vials
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
WO2006051106A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308264A (en) * 1981-01-28 1981-12-29 Abbott Laboratories Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
JPH05238936A (en) * 1992-02-27 1993-09-17 Dainippon Pharmaceut Co Ltd Aqueous liquid agent of calcitriol
DE4338046A1 (en) * 1993-11-08 1995-05-11 Dietl Hans Fat soluble drug-containing liquid pharmaceutical preparation for oral use

Also Published As

Publication number Publication date
WO1996036340A1 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
AU4809596A (en) Nanosuspensions for intravenous administration
AU7572196A (en) Pharmaceutical formulations
AU698992B2 (en) Pharmaceutical, orally applicable composition
AU5945396A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
AU7547196A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU5945296A (en) Medicament for nasal administration
AU5402296A (en) Pharmaceutical composition for transdermic administration
AU4821096A (en) Benzazepine-, benzoxazepine- and benzothiazepine-N-acetic derivatives, process for their preparation and pharmaceutical compositions containing them
AU6818196A (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
AU5651696A (en) Substituted 1-phenyl-3-pyrazolecarboxamides active on nurotensin receptors, their preparation and pharmaceutical compositions containing them
AU6874296A (en) Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
AU5779196A (en) Novel 2-amino-3-phenylpropionic acid derivatives
AU4329396A (en) Use of 3,4-diphenylchromans
EP0747346A3 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
AU1166097A (en) Indoloquinone derivatives as bioreductive agents
AU5861396A (en) Stable aqueous formulations of 1alpha,25-dihydroxycholecalci ferol for parenteral administration
AU5058196A (en) Process for the preparation of 1,1-difluoroethane
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
AU5347996A (en) Preparation for oral administration
AU4946896A (en) Novel bi-tryptaminic derivatives, preparation process and utilization as drugs
AU7291096A (en) Process for the preparation of anti-malarial drugs
AU7000496A (en) Anti-inflammatory antisense drug
AU4547896A (en) 4-oxo-2-butenoic acid derivatives
AU4956193A (en) Stable, highly concentrated formulations of fluorescein derivatives
AU5635496A (en) Derivatives of 2,3:4,6-di-o-isopropylidene-alpha-l-xylo-2-he xulofluranosonic acid